These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 19056134

  • 1. Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry.
    Campo G, Saia F, Percoco G, Manari A, Santarelli A, Vignali L, Varani E, Benassi A, Sangiorgio P, Tarantino F, Magnavacchi P, De Palma R, Guastaroba P, Marzocchi A.
    Int J Cardiol; 2010 Apr 15; 140(2):154-60. PubMed ID: 19056134
    [Abstract] [Full Text] [Related]

  • 2. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C, Magro M, Boersma E, Onuma Y, Nauta S, Daemen J, Gaspersz M, van Geuns RJ, van der Giessen W, van Domburg R, Serruys P.
    J Invasive Cardiol; 2011 Aug 15; 23(8):336-41. PubMed ID: 21828397
    [Abstract] [Full Text] [Related]

  • 3. Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial.
    Violini R, Musto C, De Felice F, Nazzaro MS, Cifarelli A, Petitti T, Fiorilli R.
    J Am Coll Cardiol; 2010 Feb 23; 55(8):810-4. PubMed ID: 20170821
    [Abstract] [Full Text] [Related]

  • 4. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grilli R, Maresta A.
    Circulation; 2007 Jun 26; 115(25):3181-8. PubMed ID: 17562952
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH, Fang Q, Zhang SY, Shen ZJ, Fan ZJ, Jin XF, Zeng Y, Liu ZY, Xie HZ, Yang M.
    Chin Med J (Engl); 2012 Aug 26; 125(16):2803-6. PubMed ID: 22932070
    [Abstract] [Full Text] [Related]

  • 6. Long-term efficacy and safety of drug-eluting stent implantation for patients with multiple coronary chronic total occlusions.
    Zhang J, Han YL, Li Y, Wang SL, Jing QM, Wang XZ, Ma YY, Luan B, Wang G, Wang B.
    Chin Med J (Engl); 2010 Apr 05; 123(7):789-93. PubMed ID: 20497665
    [Abstract] [Full Text] [Related]

  • 7. Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.
    Jensen LO, Maeng M, Thayssen P, Kaltoft A, Tilsted HH, Bøttcher M, Lassen JF, Hansen KN, Krusell LR, Rasmussen K, Pedersen KE, Pedersen L, Paaske Johnsen S, Sørensen HT, Thuesen L.
    Circ Cardiovasc Interv; 2008 Dec 05; 1(3):176-84. PubMed ID: 20031676
    [Abstract] [Full Text] [Related]

  • 8. Long-term safety and effectiveness of drug-eluting stents compared to bare metal stents following successful PCI in non-ST-elevation myocardial infarction: findings from the Guthrie Health Off-Label StenT (GHOST) Registry.
    Harjai KJ, Sattur S, Orshaw P, Boura J.
    J Interv Cardiol; 2012 Feb 05; 25(1):28-36. PubMed ID: 21981467
    [Abstract] [Full Text] [Related]

  • 9. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).
    Daemen J, Tanimoto S, García-García HM, Kukreja N, van de Sande M, Sianos G, de Jaegere PP, van Domburg RT, Serruys PW.
    Am J Cardiol; 2007 Apr 15; 99(8):1027-32. PubMed ID: 17437722
    [Abstract] [Full Text] [Related]

  • 10. Comparison of long-term clinical outcome after successful implantation of Firebird sirolimus- and Taxus paclitaxel-eluting stents in Chinese population: analysis of a large single center registry.
    Dou KF, Xu B, Yang YJ, Chen JL, Qiao SB, Wang Y, Li JJ, Qin XW, Yao M, Liu HB, Wu YJ, Chen J, Yuan JQ, You SJ, Li W, Gao RL.
    Chin Med J (Engl); 2010 Apr 05; 123(7):810-5. PubMed ID: 20497669
    [Abstract] [Full Text] [Related]

  • 11. Drug-eluting stents versus bare-metal stents in acute ST-segment elevation myocardial infarction. a single-center experience with long-term follow up.
    Palmieri C, Ravani M, Trianni G, Gianetti J, Vaghetti M, Rizza A, Paradossi U, Beqiri A, Berti S.
    J Invasive Cardiol; 2010 Apr 05; 22(4):151-8. PubMed ID: 20351384
    [Abstract] [Full Text] [Related]

  • 12. Clinical results of drug eluting stents compared to bare metal stents for patients with ST elevation acute myocardial infarction.
    Kornowski R, Vaknin-Assa H, Lev E, Ben-Dor I, Teplitsky I, Rechavia E, Brosh D, Fuchs S, Assali A.
    Acute Card Care; 2008 Apr 05; 10(3):167-72. PubMed ID: 18803074
    [Abstract] [Full Text] [Related]

  • 13. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.
    Gioia G, Benassi A, Mohendra R, Chowdhury K, Masood I, Matthai W.
    Catheter Cardiovasc Interv; 2008 Jul 01; 72(1):13-20. PubMed ID: 18561143
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial.
    Kaltoft A, Kelbaek H, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.
    J Am Coll Cardiol; 2010 Aug 17; 56(8):641-5. PubMed ID: 20688033
    [Abstract] [Full Text] [Related]

  • 15. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.
    Yan BP, Ajani AE, New G, Duffy SJ, Farouque O, Shaw J, Sebastian M, Lew R, Brennan A, Andrianopoulos N, Reid C, Clark DJ, Melbourne Interventional Group Investigators.
    Int J Cardiol; 2008 Nov 28; 130(3):374-9. PubMed ID: 18706719
    [Abstract] [Full Text] [Related]

  • 16. Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).
    Hamirani YS, Jibrin I, Abraham D, Merriman B, Wenz C, Bahr RD.
    Crit Pathw Cardiol; 2008 Dec 28; 7(4):232-8. PubMed ID: 19050419
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions.
    Han YL, Zhang J, Li Y, Wang SL, Jing QM, Yi XH, Ma YY, Luan B, Wang G, Wang B.
    Chin Med J (Engl); 2009 Mar 20; 122(6):643-7. PubMed ID: 19323927
    [Abstract] [Full Text] [Related]

  • 18. Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.
    Chong E, Poh KK, Liang S, Lee RC, Low A, Teo SG, Tan HC.
    J Interv Cardiol; 2010 Apr 20; 23(2):101-8. PubMed ID: 20236214
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
    Ma HY, Zhou YJ, Dick RJ, Shi DM, Liu YY, Cheng WJ, Guo YH, Wang JL, Ge HL.
    Chin Med J (Engl); 2008 May 20; 121(10):887-91. PubMed ID: 18706201
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.
    Lee CW, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Yun SC, Seong IW, Lee JH, Lee NH, Cho YH, Cheong SS, Lim DS, Yang JY, Lee SG, Kim KS, Yoon J, Jeong MH, Seung KB, Hong TJ, Park SJ, ZEST-AMI Investigators.
    Am J Cardiol; 2009 Nov 15; 104(10):1370-6. PubMed ID: 19892052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.